DERMAVISION SOLUTIONS
Melanoma is the deadliest skin cancer. Representing 95% of all skin cancer’s deaths. Since 1970’s the incidence has increased 360%, leading to one person dying of melanoma every hour in Europe.
OUR VISION
The two-step method of follow-up is known to be the best possible practice to early detect melanoma. Unfortunately, it usually implies using different manual devices, which consumes time and resources. It is moment to push technology further and liberate qualified specialists from capturing images, so they can focus on the important part: the diagnoses. This is the main reason why Dermavision Solutions has created Deviskan, a device capable of gathering both clinical and dermatoscopic images automatically in a single procedure of just five minutes. Being the first and only device worldwide to capture dermatoscopic images of a single lesion without human intervention.
MACHINE LEARNING
COMPLETELY AUTOMATIC
STANDARDIZATION
SCAN IN JUST 5′
HOW IT WORKS?
Deviskan uses artificial intelligence and the most advanced vision system to gather the images required to detect melanoma, following two steps:
FIRST STEP
Clinical images are acquired and processed by a machine learning algorithm + ABCDE rules to asses malignity.
Dermatoscopic images of potential malignant are captured automatically to ease dermatologist’s diagnose.
SECOND STEP
SECOND STEP
Dermatoscopic images of potential malignant are captured automatically to ease dermatologist’s diagnose.
THE BENEFITS OF DEVISKAN
Deviskan is designed to fully scan a patient in just 5 minutes and therefore it has some benefits to stand out.
92% time reduction to gather data.
Overall cost reduced 83%.
Standardized procedure.
PRESS
AWARDS
PUBLICATIONS
Most popular article during the congress!
CONTACT US
Dermavision Solutions S.L. ha sido beneficiaria de un Proyecto subvencionado por el CDTI con la colaboración del Ministerio de Ciencia e Innovación. Número de expediente SNEO-20201346
